Tuesday | 7 July, 2009
CSO

Stories about: Newman

  • +

    Evolution of the CSO 11/06/2009 07:20:00

    It's been almost 15 years since David Kent first came to Genzyme, a biotech firm headquartered in Cambridge, Mass., that develops medical treatments for ailments such as certain genetic diseases and some forms of cancer. In 1994, the company had less than $200 million in sales, and only about 1,000 employees-a stark contrast to its worldwide workforce of 11,000 today and the $4.6 billion in revenue it reported in 2008.
  • +

    10 tech-management tips 18/01/2007 13:19:50

    Ten simple tips to manage your enterprise technology.
  • +

    The Seven Deadly Sins of Records Retention (And how to avoid them) 11/10/2006 12:28:37

    Sure, you're thinking, records retention can be deadly. Deadly dull
  • +

    Deutsche Bank Tries to Marry Wireless and Security 08/05/2003 11:02:39

    A company looking to beef up the security of its wireless operations should start with its own policies and standards, according to Ken Newman, director of security and risk management at Deutsche Bank AG.
Additional Resources
Newsletter Subscription
Sign up for our CSO Online newsletters!
RSS Feeds
ARN Polls

Is your company prepared for a cyber attack?

Yes
No
View Results
 
Whitepaper

Reducing the risk of insider abuse

The potential for insider abuse can never be eliminated completely, but the steps outlined in this white paper can reduce the potential for such abuse. Read on to ensure no one person can alter your operations to their personal advantage or to the detriment of your organisation.

Sponsored Links